The strongest fact: Micron is spending at twice its old pace
The clearest verified number in this period's AI-infrastructure story comes from a company that makes memory chips. Micron Technology spent $7.676 billion on capital expenditure (money for factories and equipment) in fiscal 2023.1 That rose to $8.386 billion in fiscal 20241 and to $15.857 billion in fiscal 2025.1 By our arithmetic, that is a jump of about 89% in a single year and roughly double the fiscal 2023 level. All three figures are checked against SEC filings.
The quarterly figures show the same acceleration. Spending in the first quarter of fiscal 2024 was $1.796 billion.1 It was $3.206 billion in the first quarter of fiscal 20251 and $5.389 billion in the first quarter of fiscal 2026.1 That is about three times the level of two years earlier, on our calculation.
The scale matters to ordinary investors because Micron is not a niche supplier. Our entity graph records it as a supplier to Amazon Web Services and to Meta Platforms, and it is located in Taiwan.4 When customers like these want more computing power, companies like Micron are asked to build the capacity. Our dossier does not say how much of any index fund is invested in Micron, so we do not guess at your exposure.
The money behind it
Micron's filings also show the balance sheet growing. Cash was $9.642 billion at the end of fiscal 2025.2 Cash was $10.163 billion in the third quarter of fiscal 20252 and $24.995 billion in the third quarter of fiscal 2026.2 That is about two and a half times as much in a year. Cash in the second quarter of fiscal 2026 was $13.908 billion,2 so most of that increase came in a single quarter.
Costs have risen far more slowly than investment. Cost of revenue, the direct cost of making what Micron sells, was $16.956 billion in fiscal 2023,3 $19.498 billion in fiscal 20243 and $22.505 billion in fiscal 2025.3 That is a rise of about 15% in fiscal 2025, set against the roughly 89% rise in capital spending. In the second quarter of fiscal 2026 the figure was $6.105 billion, against $5.090 billion a year earlier.3
We have to be careful here. The verified set does not include Micron's revenue or profit, so these numbers cannot tell you how profitable the buildout is. They show a company spending much more while holding more cash. That is consistent with strong demand. It is not proof that the spending will earn its return.
Power for the data centers: bullish, with reliability caveats
Analysts are looking beyond chips to the electricity that AI data centers need. Nicholas Amicucci argued that Bloom Energy's ability to provide reliable, dispatchable power (power that can be switched on when needed) to a volatile demand profile differentiates it from competitors.6 The same piece notes Bloom's inclusion in the Russell 1000 index and an expansion of its AI infrastructure partners.6 Our measurement shows that only 46% of 520 checked claims from that source held up, so we treat this as one analyst's enthusiasm and not as a finding.
On the equipment side, Baker Hughes executive Lorenzo Simonelli described orders in its IET division as “orders doubling year-over-year to a record $7.1 billion.”7 The company is targeting Horizon 2 IET orders above $45 billion.7 Analyst Carlos Escalante asked on the call about the drivers of record IET orders and margins.7 That source held up on 57% of 881 checked claims.
For NuScale Power, the small-reactor developer, Bank of America analyst Rinny Singh reiterated a buy rating in early August with a $12 price target, implying roughly 24% upside over 12 months.8 The same article says the shares have fallen nearly 40%.8 The source of that article holds up poorly in our checks: 22% of only 18 claims. Treat the forecast with caution.
Where analysts say the price has run ahead
Quantum computing is the clearest case. Melissa Tucker said D-Wave (QBTS) trades at a stretched 171x price-to-sales multiple versus peers. That means investors pay $171 for every $1 of annual sales. She cited projected 2026 revenue near $35 million and a fair value estimate of $9.50 per share, which she said implies roughly 40% downside. She pointed to a delayed technology roadmap and D-Wave's reliance on SkyWare amid IonQ's pending acquisition of that supplier.5 Our entity graph records IonQ as a direct competitor of D-Wave.4
The stock itself has been volatile. It fell about 10% on Tuesday to $17.64, down $1.88, after a 20% surge the previous session on an expanded AT&T partnership and a bullish analyst initiation.5 It remains lower by 25% over the past month.5 Here the market is paying a very high price for a business that is still small. The reporting also shows how quickly sentiment can swing in both directions. The source held up on 57% of 881 checked claims.
The consumer: no clean recovery
While AI companies attract confident targets, consumer-facing companies draw cautious ones. Our analysis, and it is ours, is that the picture looks K-shaped. Some companies and shoppers are doing well while others lag, and no single pattern fits them all.
Levi Strauss shows the stronger side. Kendall Toscano reiterated a Buy rating and a $27 price target, calling it a compelling opportunity to own a brand moving toward “higher-quality, consistent growth.”9 The company is pushing a value label, Signature by Levi Strauss, and a premium Blue Tab line where jeans can cost between $200 and $350.9 The strategy is to reach shoppers at both ends of the budget range.
Nike shows the harder side. Lorraine Hutchinson at Bank of America lowered the price target because Nike's sales recovery is taking longer than expected.10 The article says shoppers have become harder to win back, with competitors including Adidas, On, Hoka, New Balance, Anta and Li-Ning.10
Wendy's was marked down further. Seaport Global Securities initiated coverage on September 16, 2026, with analyst Eric Gonzalez rating the stock neutral.12 The shares declined by nearly 6% that day, adding to a downward trend since the collapse of a take-private plan.14
Credit is the quieter worry. Capital One put more than $35 billion into acquiring Discover. It has racked up $1.8 billion in integration expenses, and higher-than-expected expenses contributed to back-to-back profit misses.11 Analyst Stephen Biggar suggested that a fairly large reserve build last quarter may have been read as a negative because it signaled “that they expect some weakness or deterioration in credit quality.”11 A reserve build means the bank is setting aside more money for loans that may go bad.
Event risk on the calendar
Two single-stock events add uncertainty. Goldman Sachs analyst Andrea Newkirk resumed coverage of Iovance Biotherapeutics with a buy rating and a $15 price target, which sent the shares higher.13 Separately, the FDA has set a target decision date of November 14, 2026, for Summit Therapeutics' ivonescimab application.14 Outcomes like these can move a stock sharply in either direction regardless of the wider market. In the chip sector, ASML rose over 4% on September 4 in a sympathy rally after a highly bullish analysis of another chip name.14 That shows how one analyst's call can lift related stocks.
What to watch
- Whether Micron's capital spending keeps rising, and whether its revenue and profit rise with it. The verified data shows the spending but not the payoff.
- Whether D-Wave's revenue approaches the roughly $35 million projection, and how the IonQ and SkyWare deal affects it.
- Whether the November 14, 2026, FDA decision on ivonescimab goes the way analysts expect.
- Whether Capital One's credit reserves keep rising, and whether Nike and Wendy's show any recovery in sales.
